{"id":15240,"date":"2020-02-17T08:24:58","date_gmt":"2020-02-17T13:24:58","guid":{"rendered":"https:\/\/medicarereport.org\/?p=15240"},"modified":"2020-02-17T08:27:59","modified_gmt":"2020-02-17T13:27:59","slug":"fda-says-to-stop-taking-weight-loss-pill-after-finding-it-can-cause-cancer","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=15240","title":{"rendered":"FDA says to stop taking weight loss pill after finding it can cause cancer"},"content":{"rendered":"<p>(By Maia Anderson for Becker&#8217;s Hospital Review)<\/p>\n<p>Eisai, a Japan-based drugmaker, <a href=\"http:\/\/eisai.mediaroom.com\/2020-02-13-Eisai-to-Voluntarily-Withdraw-BELVIQ-R-BELVIQ-XR-R-in-the-U-S\">said<\/a> Feb. 13 it will remove its drug, Belviq, from the U.S. market after the FDA found an increased risk of cancer in people who took the weight loss drug.\u00a0 \u00a0Continue reading article <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/fda-says-to-stop-taking-weight-loss-pill-after-finding-it-can-cause-cancer.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7883\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\" alt=\"\" width=\"179\" height=\"181\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Maia Anderson for Becker&#8217;s Hospital Review) Eisai, a Japan-based drugmaker, said Feb. 13 it will remove its drug, Belviq,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[],"class_list":["post-15240","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15240"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15240\/revisions"}],"predecessor-version":[{"id":15243,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15240\/revisions\/15243"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}